Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FERRIC CARBOXYMALTOSE Cause Movement disorder? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Movement disorder have been filed in association with FERRIC CARBOXYMALTOSE (Injectafer). This represents 0.1% of all adverse event reports for FERRIC CARBOXYMALTOSE.

11
Reports of Movement disorder with FERRIC CARBOXYMALTOSE
0.1%
of all FERRIC CARBOXYMALTOSE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Movement disorder From FERRIC CARBOXYMALTOSE?

Of the 11 reports, 3 (27.3%) required hospitalization, and 2 (18.2%) were considered life-threatening.

Is Movement disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FERRIC CARBOXYMALTOSE. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does FERRIC CARBOXYMALTOSE Cause?

Hypophosphataemia (1,046) Nausea (874) Dyspnoea (737) Headache (594) Dizziness (528) Pain (511) Urticaria (509) Pruritus (486) Maternal exposure during pregnancy (468) Vomiting (396)

What Other Drugs Cause Movement disorder?

SECUKINUMAB (788) TOFACITINIB (679) FINGOLIMOD (648) METHOTREXATE (610) PREGABALIN (572) CARBIDOPA\LEVODOPA (545) DALFAMPRIDINE (428) ACETAMINOPHEN\PROPOXYPHENE (399) PROPOXYPHENE (399) ADALIMUMAB (366)

Which FERRIC CARBOXYMALTOSE Alternatives Have Lower Movement disorder Risk?

FERRIC CARBOXYMALTOSE vs FERRIC DERISOMALTOSE FERRIC CARBOXYMALTOSE vs FERRIC HYDROXIDE FERRIC CARBOXYMALTOSE vs FERRIC MALTOL FERRIC CARBOXYMALTOSE vs FERRIC OXYHYDROXIDE FERRIC CARBOXYMALTOSE vs FERROUS

Related Pages

FERRIC CARBOXYMALTOSE Full Profile All Movement disorder Reports All Drugs Causing Movement disorder FERRIC CARBOXYMALTOSE Demographics